DE2149744A1 - 19-Nor-sprioxenon als anabolisches Mittel - Google Patents

19-Nor-sprioxenon als anabolisches Mittel

Info

Publication number
DE2149744A1
DE2149744A1 DE19712149744 DE2149744A DE2149744A1 DE 2149744 A1 DE2149744 A1 DE 2149744A1 DE 19712149744 DE19712149744 DE 19712149744 DE 2149744 A DE2149744 A DE 2149744A DE 2149744 A1 DE2149744 A1 DE 2149744A1
Authority
DE
Germany
Prior art keywords
spirox
per
anabolic
lower alkyl
dihydro
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
DE19712149744
Other languages
German (de)
English (en)
Inventor
Arth Glen Edward
Patanclli Dolores Jean
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Publication of DE2149744A1 publication Critical patent/DE2149744A1/de
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/06—Anabolic agents
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/168—Steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Food Science & Technology (AREA)
  • Animal Husbandry (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Neurology (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
DE19712149744 1970-10-06 1971-10-05 19-Nor-sprioxenon als anabolisches Mittel Pending DE2149744A1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US7863670A 1970-10-06 1970-10-06

Publications (1)

Publication Number Publication Date
DE2149744A1 true DE2149744A1 (de) 1972-04-13

Family

ID=22145320

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19712149744 Pending DE2149744A1 (de) 1970-10-06 1971-10-05 19-Nor-sprioxenon als anabolisches Mittel

Country Status (6)

Country Link
US (1) US3670079A (enExample)
AU (1) AU454533B2 (enExample)
CA (1) CA968710A (enExample)
DE (1) DE2149744A1 (enExample)
FR (1) FR2110251B1 (enExample)
GB (1) GB1350114A (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2711652A1 (de) * 1976-05-10 1977-12-01 Richardson Merrell Inc Verfahren zur wachstumsbeschleunigung bei wiederkaeuern und gefluegel

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU4093799A (en) 1998-05-22 1999-12-13 Board Of Trustees Of The Leland Stanford Junior University Bifunctional molecules and therapies based thereon
CZ20023993A3 (cs) * 2000-06-26 2004-02-18 Pfizer Products Inc. Pyrolo [2,3-d]pyrimidinové sloučeniny jako imunosupresivní činidla
CN101100472A (zh) * 2001-04-30 2008-01-09 美国拜尔公司 4-氨基-5,6-取代的噻吩并[2,3-d]嘧啶化合物及其应用
ATE445838T1 (de) 2001-07-25 2009-10-15 Raptor Pharmaceutical Inc Zusammensetzungen und verfahren zur modulation des transports durch die blut-hirn-schranke
AU2006239221C1 (en) 2005-04-28 2012-08-16 Otsuka Pharmaceutical Co., Ltd. Pharma-informatics system
WO2007035716A2 (en) 2005-09-16 2007-03-29 Raptor Pharmaceutical Inc. Compositions comprising receptor-associated protein (rap) variants specific for cr-containing proteins and uses thereof
PL2384326T3 (pl) 2008-08-20 2014-09-30 Zoetis Services Llc Związki pirolo[2,3-d]pirymidyonowe
PT3395372T (pt) 2009-02-20 2022-05-05 Enhanx Biopharm Inc Sistema de entrega de medicamentos à base de glutationa
TWI556839B (zh) 2009-05-06 2016-11-11 研究室護膚股份有限公司 包含活性劑－磷酸鈣粒子複合物之皮膚遞送組成物及其使用方法
NL2022471B1 (en) 2019-01-29 2020-08-18 Vationpharma B V Solid state forms of oclacitinib

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3254074A (en) * 1962-04-25 1966-05-31 Merck & Co Inc Spiroxenones

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2711652A1 (de) * 1976-05-10 1977-12-01 Richardson Merrell Inc Verfahren zur wachstumsbeschleunigung bei wiederkaeuern und gefluegel

Also Published As

Publication number Publication date
GB1350114A (en) 1974-04-18
AU3384971A (en) 1973-03-29
CA968710A (en) 1975-06-03
FR2110251B1 (enExample) 1975-06-06
US3670079A (en) 1972-06-13
FR2110251A1 (enExample) 1972-06-02
AU454533B2 (en) 1974-10-31

Similar Documents

Publication Publication Date Title
DE69034035T2 (de) Methode zur behandlung androgenbedingter krankheiten
DE69033020T2 (de) Kombinationstherapie zur prophylaxe und/oder behandlung benigner prostatahyperplasie
DE69427529T2 (de) Hormon-ersatztherapie
DE69125714T2 (de) Zusammensetzung für die behandlung des humanen prostata adenokarzinom
DE69430209T2 (de) Verwendung von aldosteronantagonisten zur hemmung von myocardfibrose
DE60121928T2 (de) Verfahren zur herstellung von den trans-4-n-butylcyclohexanoicsaüre- und undecanoicsaüreestern von (7-alpha,11-beta)-dimethyl-17 beta -hydroxy-4-estren-3-one und deren medizynische anwendung
EP1319404A2 (de) Mittel zur Behandlung und/oder Prophylaxe von Tumoren der Brustdrüsen
DE2149744A1 (de) 19-Nor-sprioxenon als anabolisches Mittel
DE2818586C2 (enExample)
DE69721462T2 (de) Verfahren zur Förderung von Ovulation und Geburt bei Säugetieren
DE69230069T2 (de) Steroide enthaltende zusammensetzungen zur anwendung am auge und ihre verwendung zur behandlung des glaukoms
EP0083925B1 (de) Verfahren zur Behandlung der Azyklie bei Schafen oder Rindern
DE2548413A1 (de) Depotpraeparate in oeliger ungesaettigter loesung zur intramuskulaeren injektion
EP0219447B1 (de) Antigestagene zur Verschiebung der endometrialen Reifung
DE2323615C2 (enExample)
DE1911467A1 (de) Mittel zum Senken des Cholesterinspiegels
DE2539824A1 (de) Pharmazeutische zubereitung
DE2449653C2 (de) Tiermastmittel
DE4216004B4 (de) Verwendung kompetitiver Progesteronantagonisten
DE2649914A1 (de) Mittel zum foerdern der fortpflanzungsfaehigkeit von haustieren
DE2059338C3 (de) Verwendung von Cyproteronacetat bei der Behandlung der Pubertas praecox
DE3633244A1 (de) Antigestagene zur hemmung der uterinen prostaglandinsynthese
Hall et al. Maintenance of sexual behavior in castrate male SW mice using the anti-androgen, cyproterone acetate
DE69228112T2 (de) Verfahren zur verbesserung des gedächtnisses und zur steigerung der lebensqualitet
EP0214924B1 (de) Oxytocin und Antigestagen zur Einleitung der Geburt

Legal Events

Date Code Title Description
OD Request for examination
OHJ Non-payment of the annual fee